Two Sigma Advisers’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.59M | Buy |
823,400
+315,200
| +62% | +$2.91M | 0.02% | 602 |
|
|
2025
Q1 | $4.36M | Buy |
508,200
+17,600
| +4% | +$151K | 0.01% | 840 |
|
|
2024
Q4 | $5.27M | Sell |
490,600
-2,900
| -0.6% | -$31.1K | 0.01% | 707 |
|
|
2024
Q3 | $2.8M | Sell |
493,500
-139,500
| -22% | -$792K | 0.01% | 922 |
|
|
2024
Q2 | $2.67M | Buy |
633,000
+584,500
| +1,205% | +$2.47M | 0.01% | 1034 |
|
|
2024
Q1 | $247K | Buy |
+48,500
| New | +$247K | ﹤0.01% | 2139 |
|
|
2023
Q4 | – | Sell |
-14,200
| Closed | -$93K | – | 2496 |
|
|
2023
Q3 | $93K | Sell |
14,200
-12,700
| -47% | -$83.2K | ﹤0.01% | 2220 |
|
|
2023
Q2 | $219K | Sell |
26,900
-153,700
| -85% | -$1.25M | ﹤0.01% | 2072 |
|
|
2023
Q1 | $1.55M | Buy |
180,600
+71,500
| +66% | +$613K | ﹤0.01% | 1408 |
|
|
2022
Q4 | $1.01M | Buy |
109,100
+67,500
| +162% | +$625K | ﹤0.01% | 1559 |
|
|
2022
Q3 | $429K | Buy |
41,600
+27,700
| +199% | +$286K | ﹤0.01% | 1907 |
|
|
2022
Q2 | $139K | Sell |
13,900
-17,100
| -55% | -$171K | ﹤0.01% | 2347 |
|
|
2022
Q1 | $382K | Buy |
+31,000
| New | +$382K | ﹤0.01% | 2112 |
|